Genient appoints Brijesh Singh as CEO, bringing over 20 years of molecular diagnostics leadership from Siemens Healthineers.
In March 2026, Genient signed an exclusive distribution agreement with Singapore's AIT Biotech to sell its abSEQ™ sequencer and abTRON™ platform in India.
The partnership aims to provide ISO‑certified, high‑throughput NGS solutions for infectious disease, oncology, AMR, and viral drug‑resistance testing across Indian labs.
Founder Director Anil Kumar emphasizes expanding affordable, scalable genomics diagnostics to district hospitals and research institutes, strengthening Genient’s market position.